Status:
WITHDRAWN
Neuroendocrine and Adrenal Tumors
Lead Sponsor:
University of Pennsylvania
Conditions:
Neuroendocrine Tumors
Adrenal Tumor
Eligibility:
All Genders
18-90 years
Brief Summary
This is a prospective study of rare neuroendocrine and adrenal tumors. Subjects will be enrolled via informed consent, and blood and/or saliva and tissue will be collected. This is designed to work in...
Eligibility Criteria
Inclusion
- diagnosed with neuroendocrine and/or an adrenal tumor
Exclusion
- pregnant women
- prisoners
- people under the age of 18
Key Trial Info
Start Date :
December 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2028
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04432532
Start Date
December 1 2025
End Date
January 1 2028
Last Update
February 10 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.